Ignite Creation Date:
2025-12-24 @ 2:00 PM
Ignite Modification Date:
2026-04-10 @ 6:00 PM
Study NCT ID:
NCT02879695
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-15
First Post:
2016-08-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-25
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-07-18
Completion Date Type:
ESTIMATED
First Submit Date:
2016-08-23
First Submit QC Date:
None
Study First Post Date:
2016-08-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-08-07
Results First Submit QC Date:
None
Results First Post Date:
2024-10-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-01
Last Update Post Date:
2025-08-15
Last Update Post Date Type:
ACTUAL